Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$218.0K
7K shares
What this filing means
GHEUENS SARAH plans to sell 7K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $218.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001439222-26-000051
Officer· Chief Medical Officer
Since Sep 2021
7K
Shares to sell
$218.0K
Approx. market value
2.94K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
4/2/2026
2.94KTotal acquired2.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/2/2026 | Vesting of Restricted Stock Units Not Applicable | 2.94K | — |
| Total | 2.94K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.05K
Market value
$117.4K
3/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.94K
Market value
$100.5K
4/2/2026
Total
Units
7K
Value
$218.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 4.05K | $117.4K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 2.94K | $100.5K | Nasdaq | Planned |
| Total | 7K | $218.0K | ||